Outset Medical Inc. (OM)
NASDAQ: OM
· Real-Time Price · USD
19.43
0.93 (5.03%)
At close: May 15, 2025, 3:59 PM
19.45
0.13%
After-hours: May 15, 2025, 07:59 PM EDT
Company Description
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis.
It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings.
The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015.
Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Outset Medical Inc.
| Country | United States |
| IPO Date | Sep 15, 2020 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 354 |
| CEO | Leslie L. Trigg |
Contact Details
Address: 3052 Orchard Drive San Jose, California United States | |
| Website | https://www.outsetmedical.com |
Stock Details
| Ticker Symbol | OM |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001484612 |
| CUSIP Number | 690145107 |
| ISIN Number | US6901451079 |
| Employer ID | 20-0514392 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Leslie L. Trigg | President, Chief Executive Officer & Chairman |
| Nabeel Ahmed | Chief Financial Officer |
| Amelia Merrill | Vice President of People Operations & Culture |
| Dinamarie Stefani | Senior Vice President of Regulatory Affairs & Quality Assurance |
| Dr. Michael Aragon M.D. | Chief Medical Officer |
| James S. Mazzola | Head of Investor Relations |
| Jennifer Sipple | Senior Vice President of Customer Experience |
| John L. Brottem J.D. | General Counsel & Secretary |
| Laura Romike | Senior Vice President of Sales |
| Marc Nash | Senior Vice President of Operations and R&D |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 14, 2025 | 4 | Filing |
| May 14, 2025 | 3 | Filing |
| May 14, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| May 14, 2025 | DEFA14A | Filing |
| May 14, 2025 | 8-K | Current Report |
| May 08, 2025 | 10-Q | Quarterly Report |
| May 07, 2025 | 8-K | Current Report |
| Apr 11, 2025 | DEFA14A | Filing |
| Apr 11, 2025 | DEF 14A | Filing |
| Apr 07, 2025 | SCHEDULE 13G/A | [Amend] Filing |